UPDATE: Bank of America Downgrades Molina Healthcare from Buy to Underperform

Bank of America has published a report on Molina Healthcare MOH Downgrading the stock from Buy to Underperform and lowering the price target to $18.00. In the report, Bank of America wrote, "We are downgrading MOH shares to Underperform (from Buy) with a view that balance sheet reserves are not conservative and two upcoming RFP rebids in its largest markets could also pressure margins. In 2Q11, an adjusted MLR of 84.7% (excluding 55bp from a Utah settlement) missed our 84.2% estimate, which assumed typical favorable seasonality after flu season ends." Bank of America downgraded Molina Healthcare from Buy to UNDERPERFORM with a price target lowered to $18.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsBank of AmericaHealth CareManaged Health CareMolina Healthcare
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!